Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Adjuvant therapy for ampullary carcinomas: The Mayo Clinic experience

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1];  [1];  [1];  [2];  [3]
  1. Department of Radiation Oncology, Mayo Clinic, Rochester, MN (United States)
  2. Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN (United States)
  3. Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX (United States)

Purpose: To determine the effects of adjuvant radiotherapy and chemotherapy for carcinoma of the ampulla of Vater. Methods and Materials: We retrospectively reviewed the records of 125 patients who underwent definitive surgery for carcinomas involving the ampulla of Vater between April 1977 and February 2005 and who survived more than 50 days after surgery. Twenty-nine of the patients also received adjuvant radiotherapy (median dose, 50.4 Gy in 28 fractions) with concurrent 5-fluorouracil chemotherapy. Adverse prognostic factors were investigated, and overall survival (OS) and local and distant failure were estimated. Results: Adverse prognostic factors for decreased OS by univariate analysis included lymph node (LN) involvement, locally advanced tumors (T3/T4), and poor histologic grade. By multivariate analysis, positive LN status (p = 0.02) alone was associated with decreased OS. The addition of adjuvant radiotherapy and chemotherapy improved OS for patients with positive LN (p = 0.01). Median survival for positive LN patients receiving adjuvant therapy was 3.4 years, vs. 1.6 years for those with surgery alone. Conclusions: The addition of adjuvant radiotherapy and 5-fluorouracil chemotherapy may improve OS in patients with LN involvement. The effect of adjuvant therapy on outcomes for patients with poor histologic grade or T3/T4 tumors without LN involvement could not be assessed.

OSTI ID:
20850129
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 2 Vol. 66; ISSN IOBPD3; ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

Review of Adjuvant Radiochemotherapy for Resected Pancreatic Cancer and Results From Mayo Clinic for the 5th JUCTS Symposium
Journal Article · Thu Oct 01 00:00:00 EDT 2009 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21282034

Adjuvant Therapy for Gallbladder Carcinoma: The Mayo Clinic Experience
Journal Article · Tue Sep 01 00:00:00 EDT 2009 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21282006

Role of Adjuvant Chemoradiation Therapy in Adenocarcinomas of the Ampulla of Vater
Journal Article · Fri Feb 29 23:00:00 EST 2008 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21039787